Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-31

Clinical Trial Update: Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of gemcitabine and cisplatin for penile epidermoid carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cisplatin (Platinol) (cisplatin)
  • Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Genital Neoplasms, Male | Phase 2 | Status: COMPLETED